Explore News By Topic

08/04/2015

6 New Movember Foundation – PCF Challenge Awards Advance Precision Medicine and Novel Treatments for Lethal Prostate Cancer

Nearly $7 Million to Fund Lifesaving Research SANTA MONICA, CA August 4, 2015 -- The Prostate Cancer Foundation (PCF) announces that it has received nearly $7 million from the Movember Foundation, a valued partner since 2007. These funds were made possible by the 2014 Movember U.S. Campaign and will support... Read More

    06/19/2015

    EARLIER CHEMOTHERAPY MAY EXTEND PATIENT SURVIVAL IN MULTIPLE PROSTATE CANCER SETTINGS

    June 19, 2015 -- Chemotherapy has traditionally been used to treat prostate cancer patients only after they have developed resistance to hormone therapy. However, two new studies presented at the 2015 American Society for Clinical Oncology (ASCO) Annual Meeting found that the addition of taxane chemotherapy extended survival in several... Read More

      06/16/2015

      Prostate Cancer Foundation Steps Into The Ring To Knock Out Prostate Cancer For Good

      Taps boxing legend Evander Holyfield and communications firm (add)ventures to produce public service announcement aimed at African-American men PR Newswire, SANTA MONICA, CA (June 16, 2015) -- The Prostate Cancer Foundation is throwing a one-two punch to knock out prostate cancer for good with the recent production of a public... Read More

        06/02/2015

        THE DISCOVERY OF NEW MOLECULAR MECHANISMS THAT MAY LINK OBESITY AND HIGH RISK PROSTATE CANCER

        What this means for patients: Obesity is a known risk factor for prostate cancer, but the reasons for this remain unknown. This study identifies expression of chromatin remodeling genes as a likely mechanism linking these processes, and may lead to the development of therapies for obesity-related prostate cancer. June 2,... Read More

        05/26/2015

        The PARP-inhibitor Olaparib may be the first precision medicine therapy to reach prostate cancer patients

        What this means for patients: A Phase II clinical trial found that up to one-third of metastatic prostate cancer patients have mutations in genes that control DNA repair in their tumors, causing them to selectively respond to treatment with olaparib. This therapy was recently approved for ovarian cancer patients who... Read More

          05/26/2015

          BOXING LEGEND AND FIVE-TIME HEAVYWEIGHT CHAMPION OF THE WORLD EVANDER HOLYFIELD GETS READY TO KNOCK OUT PROSTATE CANCER WITH PUBLIC SERVICE ANNOUNCEMENT FILMED IN PROVIDENCE

          Providence, R.I. (May 26, 2015) – Are you ready to rumble? Coming soon to knock out prostate cancer is boxing legend and five-time heavyweight champion of the world, Evander Holyfield. Since his retirement from boxing in 2011, Holyfield has dedicated his time to philanthropic activities through Team Holyfield, and will be... Read More

          The Prostate Cancer Foundation-International Prostate Cancer Dream Team Demonstrates The Value Of Cancer Precision Medicine Strategies

          What this means for patients: The Prostate Cancer Foundation (PCF)-sponsored International Prostate Cancer Dream Team has released results from a landmark study that uses gene sequencing technologies to identify the mutations present in tumors from individual prostate cancer patients. These results can be used to match each patient with medicines... Read More

            04/20/2015

            PROSTATE CANCER FOUNDATION (PCF) ANNOUNCES INAUGURAL STUPSKI PRIZE IN PROSTATE CANCER COMPUTATIONAL ONCOLOGY

            SANTA MONICA, CA April 20, 2015—The Prostate Cancer Foundation(PCF) is pleased to announce the Stupski Prize in Prostate Cancer Computational Oncology, a first-in-field initiative designed to attract novel ideas to the rapidly changing field of large-scale cancer bioinformatics. These solutions will help clinicians and researchers optimize treatment for individual prostate... Read More

              04/16/2015

              2015 AACR-Prostate Cancer Foundation Scholar-in-Training Award Recipients

              The Prostate Cancer Foundation Scholar-in-Training Awards recognize promising young cancer researchers presenting outstanding proffered papers relating to advanced prostate cancer at the AACR Annual Meeting. The Prostate Cancer Foundation is one of 13 organizations sponsoring this highly competitive awards program in conjunction with the AACR. The 2015 AACR Annual Meeting... Read More

                03/21/2015

                Smoking May Be Linked to Prostate Cancer Return

                Mar. 21, 2015 -- Smoking doubles the risk that prostate cancer will return after surgery for the disease, a new study suggests. "This is a new analysis, but it seems to confirm results we have seen in many other types of cancer: Basically, smoking increases the risk of cancer recurrence... Read More